Abstract
We thank Dr Ryding et al for their comments on our systematic review that investigated the impact of pretreatment with clopidogrel on initial coronary patency (Thrombolysis in Myocardial Infarction trial 2/3 flow) before primary percutaneous coronary intervention (PCI) for ST-elevation myocardial infarction.1 No published randomized trials on this subject exist, so we investigated the impact of clopidogrel pretreatment by comparing treatment groups in studies in which patients received pretreatment with clopidogrel with those in which patients did not. To eliminate as …
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.